Viewing data from:

AMYVID

NDA

FLORBETAPIR F-18 | N202008 | AVID RADIOPHARMACEUTICALS INC

4 strengths2 unique patents0 unique exclusivities

Patent Timeline

2 unique patents by expiration date

Expiring < 1yr (2)Today

2027

Today

Apr. 30, 2027

Apr. 30, 2027

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

6 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 10ML (13.5-51mCi/ML)

RLD

2 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Apr 6, 2012

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
7687052	Apr 30, 2027	—	Yes	Yes		—
8506929	Apr 30, 2027	—	Yes	Yes		—

#002 — 10-30ML (13.5-51mCi/ML)

RLD

2 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Apr 6, 2012

#003 — 10-50ML (13.5-51mCi/ML)

RLD

2 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Apr 6, 2012

#004 — 10-100ML (13.5-51mCi/ML)

RLD

2 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Oct 13, 2023